Our data corroborate with previous literature studies showing the significant role of CCL2 signaling in breast cancer cells [79,80] and indicates that targeting CCL2 signaling pathway may affect various mechanisms involved in cancer progression, hence representing an attractive therapeutic target [78]. The gene discussed is CCL2; the disease is breast cancer.